Singapore markets closed
Straits Times Index
3,292.69 +10.64 (+0.32%) S&P 500
5,116.17 +16.21 (+0.32%) Dow
38,386.09 +146.43 (+0.38%) Nasdaq
15,983.08 +55.18 (+0.35%) Bitcoin USD
62,955.66 -677.18 (-1.06%) CMC Crypto 200
1,273.40 -65.67 (-4.91%)
DiaMedica Therapeutics Inc. (DMAC)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 98.31M |
| Enterprise value | 45.82M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 1.93 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -2.16 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.74 |
| 52-week change 3 | 59.88% |
| S&P500 52-week change 3 | 24.19% |
| 52-week high 3 | 4.7500 |
| 52-week low 3 | 1.5800 |
| 50-day moving average 3 | 2.7757 |
| 200-day moving average 3 | 2.7934 |
Share statistics
| Avg vol (3-month) 3 | 38.47k |
| Avg vol (10-day) 3 | 15.36k |
| Shares outstanding 5 | 37.96M |
| Implied shares outstanding 6 | 38.28M |
| Float 8 | 23.82M |
| % held by insiders 1 | 26.65% |
| % held by institutions 1 | 21.98% |
| Shares short (15 Apr 2024) 4 | 175.43k |
| Short ratio (15 Apr 2024) 4 | 3.11 |
| Short % of float (15 Apr 2024) 4 | 0.74% |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.46% |
| Shares short (prior month 15 Mar 2024) 4 | 212.62k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 15 Nov 2018 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:20 |
| Last split date 3 | 15 Nov 2018 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -30.02% |
| Return on equity (ttm) | -46.77% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -21.24M |
| Net income avi to common (ttm) | -19.38M |
| Diluted EPS (ttm) | -0.6000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 52.9M |
| Total cash per share (mrq) | 1.39 |
| Total debt (mrq) | 400k |
| Total debt/equity (mrq) | 0.78% |
| Current ratio (mrq) | 19.27 |
| Book value per share (mrq) | 1.35 |
Cash flow statement
| Operating cash flow (ttm) | -18.73M |
| Levered free cash flow (ttm) | -11.45M |
© 2024 Yahoo. All rights reserved.